Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
TalexMedical
AddedFeb 19, 2024
UpdatedJun 18, 2026
TalexMedical

TalexMedical

Seed

TalexMedical: Revolutionizing newborn ear deformity treatment with our cost-effective, non-surgical InfantEar device.

HQ
Philadelphia, PA, US
Founded
2015
Overview
Compare
Fundraising
Employees
Website

TalexMedical, founded with the mission to revolutionize the treatment of external ear deformities in newborns, offers the innovative InfantEar device. This Class I medical device provides a non-surgical, cost-effective solution for pediatricians to treat ear anomalies in an outpatient setting. Made from soft, customizable materials, InfantEar ensures increased comfort for infants, aiming to replace traditional, labor-intensive surgical procedures.

Notable individuals affiliated with TalexMedical include Dr. Scott Bartlett, the inventor of InfantEar and recipient of the 2023 Clinician of the Year award by the American Association of Plastic Surgeons. The company has achieved significant milestones by providing an accessible and efficient alternative to surgical treatments, positively impacting the pediatric healthcare market. TalexMedical's contributions have streamlined the treatment process for ear deformities, offering a practical and comfortable solution for both doctors and patients.

TalexMedical - Similar Companies

Cactus Medical logo

Cactus Medical

Preceptis Medical logo

Preceptis Medical

Early Bird Medical logo

Early Bird Medical

earlybirdmed.com

Oui-Medical. logo

Oui-Medical.

oui-medical.com

TheraB Medical logo

TheraB Medical

therabmedical.com

Dalent Medical logo

Dalent Medical

dalentmedical.com

Powers Medical Devices logo

Powers Medical Devices

powersmeddev.com

Aerin Medical logo

Aerin Medical

TAS Medical logo

TAS Medical

OtoNexus Medical Technologies logo

OtoNexus Medical Technologies

otonexus.com

PionEar Technologies logo

PionEar Technologies

pionear-tech.com

ENT Surgical logo

ENT Surgical

Excelent logo

Excelent

True Concepts Medical Technologies logo

True Concepts Medical Technologies

Proxamama logo

Proxamama

proxamama.com

TalexMedical - Quick Facts

Who are TalexMedical's competitors?

Companies similar to TalexMedical include Cactus Medical, Preceptis Medical, Early Bird Medical and Oui-Medical..

When was TalexMedical founded?

TalexMedical was founded in 2015.

Where is TalexMedical's headquarters located?

TalexMedical's headquarters is located in Philadelphia, PA, US.

When was TalexMedical's last funding round?

TalexMedical's most recent funding round was for $500k (USD) in August 2017.

How much has TalexMedical raised to-date?

As of Aug 1, 2017, TalexMedical has raised a total of $500k (USD).

How many employees does TalexMedical have?

TalexMedical has 5 employees as of Feb 4, 2024.

TalexMedical - Classification

Industry
  • Hardware
Ownership
  • Private
Technology
  • HealthTech
Geographic Exposure
  • United States
Revenue
  • Recurring
Customer
  • Consumers
Main Product
  • Medical Devices
Tags
  • Healthcare
  • Medical
  • SaaS
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 325000Chemical Manufacturing
  • 325410Pharmaceutical and Medicine Manufacturing
SIC
  • 5000Wholesale Trade-durable Goods
  • 5040Professional And Commercial Equipment And Supplies
  • 5047Medical, Dental, And Hospital Equipment And Supplies
Show 7 more industry codes
NAICS
  • 330000Manufacturing
  • 620000Health Care and Social Assistance
  • 623000Nursing and Residential Care Facilities
SIC
  • 3900Miscellaneous Manufacturing Industries
  • 8000Health Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified